Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid vs vancomycin/cefazolin in catheter-related gram-positive bloodstream infections in hemodialysis patients
2004-005159-32Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linezolid in catheter-associated bloodstream infection (CRBSI), sponsored by Pfizer. Started Mar 2005; status: completed.
02
Drugs
linezolid
03
Conditions
catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on 2004-005159-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005159-32.